Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
DALLAS - Enhabit, Inc. (NYSE:EHAB), a healthcare provider with a market capitalization of $339 million, announced Tuesday that President and CEO Barb Jacobsmeyer plans to step down from her position in July 2026, or when a successor is appointed. Jacobsmeyer, who also serves on the company’s board of directors, will depart with the full support of the board.
The home health and hospice provider has initiated a leadership succession plan and retained Russell Reynolds Associates to conduct a comprehensive search for the next CEO. According to InvestingPro data, the company maintains a GOOD overall financial health score, suggesting stable operational fundamentals during this transition period.
"I am honored to have served as the first CEO of Enhabit and to have been part of the steady progress we have made together over the past several years," Jacobsmeyer said in a press release statement.
Jeffrey Bolton, chairman of Enhabit’s board of directors, expressed gratitude for Jacobsmeyer’s leadership, noting that she "has helped to stabilize the business during her tenure and enabled the company to build on our momentum."
Enhabit operates 249 home health locations and 114 hospice locations across 34 states. The company also released its financial results for the second quarter of 2025 in a separate announcement and will hold a conference call to discuss these results on August 7.
The board has emphasized its commitment to ensuring a smooth transition as it searches for a new leader to guide the company’s next growth phase. For detailed analysis and additional insights on Enhabit’s valuation and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Enhabit Inc. reported its financial results for the first quarter of 2025, surpassing analysts’ expectations with an earnings per share (EPS) of $0.10, compared to the forecasted $0.06. However, the company experienced a slight shortfall in revenue, reaching $259.9 million against the anticipated $266.56 million. Despite the revenue miss, the positive earnings surprise highlighted operational efficiencies. Additionally, Jefferies raised its price target for Enhabit to $12.00 from $11.75, maintaining a Buy rating on the stock. Jefferies analysts noted operational improvements following Enhabit’s recent strategic initiatives. They also highlighted a robust pipeline of payor innovation, which could lead to better rates. Moreover, there is potential for further reduction in general and administrative costs, contributing to possible margin expansion. These developments reflect the company’s ongoing efforts to enhance its operational performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.